Medicalization, Pharmaceuticalization, and the Opioid Crisis in America Introduction The use disorder of opioid substan

 Medicalization, Pharmaceuticalization, and the Opioid Crisis in America

Introduction

The use disorder of opioid substances has turned out to be one of the most acute threats to the population health in the United States. In the last several decades, the perception of pain and addiction, as well as the way it is treated, has changed because of medicalization and pharmaceuticalization. Medicalization can be described as the process where human conditions, behaviors or problems are characterized and met with medical intervention as a medical problem. Pharmaceuticalization, in its turn, consists in the increasing use of medications in dealing with social, psychological, and physical problems. All these have helped considerably to the perception and response of the society to the element of pain, and this has led to the rapid surge in consumption and addiction to opioids.

Medicalization has changed the understanding of pain which is a subjective human experience to a medical condition which should be treated (probably with a help of drugs). Towards the end of the twentieth century, pain management has become a leading issue in healthcare, with organizations calling pain the fifth vital sign. The practice encouraged clinicians to emphasize more on pain relief, and it was not generally well matched with the consideration that was necessary on the long-term outcome. Pharmaceutical organizations took advantage of such change marketing opioids as suitable and secure methods to treat chronic pain, which succumbed to over-prescription. Due to this reason, medicalization enhanced the intervening role of physicians and systems that exist in the definition of normal and pathological experiences of pain that inadvertently gave way to dependency on medical solutions.

Pharmaceuticalization, as well, was part of the contribution to the opioid crisis by getting to realize that dealing with pain and addiction can only be done through drugs. The opioids and their marketing strategies were presented in the pharmaceutical companies as low-risk medications, and aggressive advertising was addressed both on the healthcare providers and the patients. This gave the impression of faith in prescription drugs as a painkiller to illness and misery. As a result of this reliance, patients got addicted to opioids and most of them started to take the illicit opioids like heroin and fentanyl upon being unable to obtain them anymore in the form of prescription. Oversaturation of pharmacological solutions not just led to addiction, but has also threatened other treatment methods such as behavioral therapy, physical rehabilitation as well as system of social support.

Medicalization and pharmaceuticalization have more than addiction rates as effects. They have influenced cultural disposition towards pain, entrenched profiteering healthcare behavior and helped limit generations of social malice. The opioid dependence still brings with it traumatic ramifications on millions of families and people as well as the deplorable state of health, economic instability, and stigmatization. In order to eliminate this crisis, there is need to begin by compensating less on the medical and pharmaceutical approaches of the problem, and the approach that incorporates prevention, education and community based care. The development of these processes is a crucial part of the determination of the creation of the sustainable solutions to the current opioid crisis.

References

Conrad, P., & Bergey, M. (2018). The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder. Social Science & Medicine, 197, 1–8. https://doi.org/10.1016/j.socscimed.2017.11.001

Dunn, K. E., Bergeria, C. L., & Huhn, A. S. (2020). A critical review of the opioid epidemic: Relationship between medicalization, pharmaceuticalization, and public health. Substance Abuse, 41(2), 135–142. https://doi.org/10.1080/08897077.2019.1698483

Lafrance, M. N., & McKenzie, H. A. (2021). Medicalization, pharmaceuticalization, and the opioid crisis: Rethinking the role of medicine in addiction. Journal of Substance Use, 26(4), 377–384. https://doi.org/10.1080/14659891.2020.1742346